Seqens Seqens

X

List of NDC API details of Tasocitinib Citrate Active Pharmaceutical Ingredient listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

Flag India
Digital Content Digital Content
TOFACITINIB CITRATE
POWDER (10kg/10kg)
BULK INGREDIENT
42765-036
2021-05-29
2024-12-31
Flag India
Digital Content Digital Content
Tofacitinib
POWDER (1kg/kg)
BULK INGREDIENT
71796-050
2022-07-29
2024-12-31
Flag Canada
Digital Content Digital Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
11712-895
2021-02-19
2024-12-31
Minakem Delmar

Iran Expo

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
TOFACITINIB CITRATE
POWDER (1kg/kg)
BULK INGREDIENT
72761-036
2024-01-10
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1g/g)
BULK INGREDIENT FOR ...
73377-084
2020-11-03
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib citrate
POWDER (1kg/kg)
BULK INGREDIENT
52076-6267
2020-12-08
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (50g/50g)
BULK INGREDIENT
71052-554
2019-09-13
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
66039-915
2015-03-11
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
69037-0072
2012-11-06
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
49574-523
2021-08-11
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (10kg/10kg)
BULK INGREDIENT
42571-289
2023-06-12
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
14501-0083
2013-11-30
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
69218-0700
2021-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT
17337-0079
2017-06-27
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate Micronized
POWDER (1kg/kg)
BULK INGREDIENT
17337-0085
2018-03-09
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
tofacitinib citrate
POWDER (1kg/kg)
BULK INGREDIENT
60715-1000
2012-11-06
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib citrate
POWDER (1kg/kg)
BULK INGREDIENT
53747-053
2016-07-05
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1kg/kg)
BULK INGREDIENT FOR ...
76397-028
2020-12-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1g/g)
BULK INGREDIENT FOR ...
76397-027
2020-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
Tofacitinib Citrate
POWDER (1g/g)
BULK INGREDIENT FOR ...
76397-026
2020-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 540737-29-9 / Tofacitinib Citrate API manufacturers, exporters & distributors?

Tofacitinib Citrate manufacturers, exporters & distributors 1

67

PharmaCompass offers a list of Tofacitinib Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tofacitinib Citrate manufacturer or Tofacitinib Citrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tofacitinib Citrate manufacturer or Tofacitinib Citrate supplier.

PharmaCompass also assists you with knowing the Tofacitinib Citrate API Price utilized in the formulation of products. Tofacitinib Citrate API Price is not always fixed or binding as the Tofacitinib Citrate Price is obtained through a variety of data sources. The Tofacitinib Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Tofacitinib Citrate

Synonyms

540737-29-9, Tasocitinib citrate, Xeljanz, Cp-690550 citrate, Tofacitinib (citrate), Tofacitinib (cp-690550) citrate

Cas Number

540737-29-9

Unique Ingredient Identifier (UNII)

O1FF4DIV0D

Tasocitinib Citrate Manufacturers

A Tasocitinib Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tasocitinib Citrate, including repackagers and relabelers. The FDA regulates Tasocitinib Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tasocitinib Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tasocitinib Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tasocitinib Citrate Suppliers

A Tasocitinib Citrate supplier is an individual or a company that provides Tasocitinib Citrate active pharmaceutical ingredient (API) or Tasocitinib Citrate finished formulations upon request. The Tasocitinib Citrate suppliers may include Tasocitinib Citrate API manufacturers, exporters, distributors and traders.

click here to find a list of Tasocitinib Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tasocitinib Citrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tasocitinib Citrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Tasocitinib Citrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Tasocitinib Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Tasocitinib Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tasocitinib Citrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Tasocitinib Citrate suppliers with NDC on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY